BRD2 and ovarian hyperstimulation syndrome: We aimed to compare human menopausal gonadotropin (hMG) and recombinantfollicle-stimulating hormone (r FSH) with respect to clinical outcomes and the development ofovarian hyperstimulation syndrome (OHSS) for patients with polycystic ovary syndrome (PCOS)treated with in vitro fertilization (IVF).